ANI Change To Netincome from 2010 to 2024

ANIP Stock  USD 63.77  1.05  1.62%   
ANI Pharmaceuticals Change To Netincome yearly trend continues to be relatively stable with very little volatility. Change To Netincome is likely to drop to about 274.5 K. During the period from 2010 to 2024, ANI Pharmaceuticals Change To Netincome destribution of quarterly values had range of 21 M from its regression line and mean deviation of  2,974,139. View All Fundamentals
 
Change To Netincome  
First Reported
2012-03-31
Previous Quarter
5.1 M
Current Value
4.3 M
Quarterly Volatility
4.2 M
 
Yuan Drop
 
Covid
Check ANI Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ANI main balance sheet or income statement drivers, such as Depreciation And Amortization of 62.8 M, Interest Expense of 28.9 M or Selling General Administrative of 157.9 M, as well as many exotic indicators such as Price To Sales Ratio of 1.94, Dividend Yield of 0.0012 or PTB Ratio of 2.18. ANI financial statements analysis is a perfect complement when working with ANI Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement ANI Pharmaceuticals' financial leverage analysis and stock options assessment as well as various ANI Pharmaceuticals Technical models . Check out the analysis of ANI Pharmaceuticals Correlation against competitors.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.

Latest ANI Pharmaceuticals' Change To Netincome Growth Pattern

Below is the plot of the Change To Netincome of ANI Pharmaceuticals over the last few years. It is ANI Pharmaceuticals' Change To Netincome historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ANI Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Change To Netincome10 Years Trend
Very volatile
   Change To Netincome   
       Timeline  

ANI Change To Netincome Regression Statistics

Arithmetic Mean1,502,734
Geometric Mean1,703,397
Coefficient Of Variation306.50
Mean Deviation2,974,139
Median1,750,165
Standard Deviation4,605,887
Sample Variance21.2T
Range21M
R-Value(0.07)
Mean Square Error22.7T
R-Squared0
Significance0.81
Slope(69,797)
Total Sum of Squares297T

ANI Change To Netincome History

2024274.5 K
2023288.9 K
2022321 K
2021-3.8 M
20203.9 M
20192.5 M
20183.4 M

About ANI Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ANI Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. ANI Pharmaceuticals investors use historical funamental indicators, such as ANI Pharmaceuticals's Change To Netincome, to determine how well the company is positioned to perform in the future. Although ANI Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in ANI Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ANI Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ANI Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ANI Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Netincome288.9 K274.5 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ANI Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ANI Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ani Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Ani Pharmaceuticals Stock:
Check out the analysis of ANI Pharmaceuticals Correlation against competitors.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for ANI Stock analysis

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is ANI Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ANI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
13.824
Earnings Share
1.61
Revenue Per Share
27.705
Quarterly Revenue Growth
0.287
Return On Assets
0.0391
The market value of ANI Pharmaceuticals is measured differently than its book value, which is the value of ANI that is recorded on the company's balance sheet. Investors also form their own opinion of ANI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ANI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ANI Pharmaceuticals' market value can be influenced by many factors that don't directly affect ANI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ANI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ANI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.